Point72 Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,095,000
| Closed | -$4.51M | – | 1417 |
|
|
2024
Q4 | $4.51M | Buy |
+1,095,000
| New | +$4.51M | 0.01% | 689 |
|
|
2022
Q4 | – | Sell |
-375,000
| Closed | -$1.04M | – | 1186 |
|
|
2022
Q3 | $1.04M | Sell |
375,000
-53,360
| -12% | -$147K | ﹤0.01% | 841 |
|
|
2022
Q2 | $1.05M | Sell |
428,360
-127,535
| -23% | -$311K | ﹤0.01% | 832 |
|
|
2022
Q1 | $2.19M | Buy |
555,895
+124,460
| +29% | +$490K | 0.01% | 784 |
|
|
2021
Q4 | $1.9M | Buy |
431,435
+221,945
| +106% | +$979K | 0.01% | 773 |
|
|
2021
Q3 | $1.3M | Buy |
209,490
+20,800
| +11% | +$129K | 0.01% | 771 |
|
|
2021
Q2 | $1.49M | Buy |
188,690
+63,690
| +51% | +$504K | 0.01% | 701 |
|
|
2021
Q1 | $1.34M | Buy |
+125,000
| New | +$1.34M | 0.01% | 726 |
|